Sandimmun 250 mg/5 ml inf. sol. (conc.) i.v. amp. Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandimmun 250 mg/5 ml inf. sol. (conc.) i.v. amp.

novartis pharma sa-nv - ciclosporin 250 mg/5 ml - concentrate for solution for infusion - 250 mg/5 ml - ciclosporin 50 mg/ml - ciclosporin

Sandimmun 250 mg/5 ml inf. sol. (conc.) i.v. amp. Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandimmun 250 mg/5 ml inf. sol. (conc.) i.v. amp.

novartis pharma sa-nv - ciclosporin 250 mg/5 ml - concentrate for solution for infusion - 250 mg/5 ml - ciclosporin 50 mg/ml - ciclosporin

Neoral-Sandimmun 50 mg soft caps. Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

neoral-sandimmun 50 mg soft caps.

novartis pharma sa-nv - ciclosporin 50 mg - capsule, soft - 50 mg - ciclosporin 50 mg - ciclosporin

Atopica 50 mg soft caps. Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atopica 50 mg soft caps.

elanco gmbh - ciclosporin 50 mg - capsule, soft - 50 mg - ciclosporin 50 mg - ciclosporin - dog

Sandimmun Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

sandimmun

novartis new zealand ltd - ciclosporin 50 mg/ml - solution for infusion - 250 mg/5ml - active: ciclosporin 50 mg/ml excipient: ethanol polyoxyl 35 castor oil - solid organ transplantation prevention of graft rejection following kidney, liver, heart, combined heart-lung, lung or pancreas allogeneic transplantations. treatment of transplant rejection in patients previously receiving other immunosuppressive agents. bone marrow transplantation prevention of graft rejection following bone marrow transplantation. prevention or treatment of graft-versus-host disease (gvhd).

Neoral Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

neoral

novartis new zealand ltd - ciclosporin 50mg;   - soft gelatin capsule - 50 mg - active: ciclosporin 50mg   excipient: corn oil dl-alpha tocopherol ethanol gelatin glycerol polyethylene glycol hydrogenated castor oil propylene glycol   titanium dioxide - solid organ transplantation prevention of graft rejection following kidney, liver, heart, combined heart-lung, lung or pancreas allogeneic transplantations. treatment of transplant rejection in patients previously receiving other immunosuppressive agents. bone marrow transplantation prevention of graft rejection following bone marrow transplantation. prevention or treatment of graft-versus-host disease (gvhd).

NEORAL ciclosporin 50mg capsules blister pack Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

neoral ciclosporin 50mg capsules blister pack

novartis pharmaceuticals australia pty ltd - ciclosporin, quantity: 50 mg - capsule, soft - excipient ingredients: propylene glycol; dl-alpha-tocopherol; ethanol; gelatin; corn glycerides; peg-40 hydrogenated castor oil; titanium dioxide; glycerol; hypromellose; purified water; isopropyl alcohol; cochineal; aluminium chloride; sodium hydroxide - changes as described in the letter 23 december 1998 from b wall.

Deximune 50 mg soft capsules Malta - Kiingereza - Medicines Authority

deximune 50 mg soft capsules

dexcel pharma gmbh carl-zeiss-straße 2 63755 alzenau, germany - ciclosporin - soft capsule - ciclosporin 50 mg - immunosuppressants

Sandimmun Con for Inf 50 mg/ml Yordani - Kiingereza - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

sandimmun con for inf 50 mg/ml

شركة مستودع الأدوية الأردني - the jordan drugstore co - ciclosporin 50 mg/ml - 50 mg/ml

SANDIMMUN NEORAL Cap 50 mg Yordani - Kiingereza - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

sandimmun neoral cap 50 mg

شركة مستودع الأدوية الأردني - the jordan drugstore co - ciclosporin 50 mg - 50 mg